ArticlePharmaceuticals (Basel, Switzerland)2025

Design, Synthesis, Anticancer Evaluation and Molecular Docking of Pyrimidine, Pyrido[4,3-d]pyrimidine and 5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidine Derivatives as Novel KRAS-G12D Inhibitors and PROTACs.

Hailong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.